EMA says there is no evidence for 4th Covid booster for general population
EMA also said continued vaccine boosters could reduce the level of antibodies
Coronavirus – EMA approves use of Novavax vaccine
The EMA granted conditional marketing authorization
EMA approves use of Pfizer vaccine for children aged 5 to 11
The doses will be lower than for people over 12